Mr. James (Jamie) Samuels has served as Chief Financial Officer of Exuma Biotech since June 2019. Mr. Samuels has 17 years of experience as a Finance leader with public and private companies. Most recently, from 2017 to 2019, he served as the CFO of Vetsource, a VC-backed provider of outsourced Veterinary pharmacy services. From 2012 to 2016 he served as the CFO of Fusheng Industrial, a PE-backed and Taiwan based global manufacturer of industrial compressors. From 2002 to 2012 he served in various CFO roles of increasing responsibility at Johnson & Johnson operating companies in Asia Pacific in medical devices, diagnostics and pharmaceuticals. His last position with Johnson & Johnson was as CFO of Xian-Janssen, Johnson & Johnson’s pharmaceutical joint-venture in China. He earned his MBA from The Wharton School at the University of Pennsylvania in 2002.